The only benefit to a delay that I can see would be to accumulate more value in the evaluation process by accumulating more sales or securing more contracts before making a final decision on an evaluation. Therefore resulting in setting a higher valuation therefore a higher price per share. The Washington trip is intriguing on multi levels. Washington usually would equate to government contracts or legislation which equates to very slow processes. I would hope that are evaluation at this point without the Washington element is enough to get us trading again. After which,the Washington news can be the caveat to a nice run up in stock price. At this point a small 1 for 5 stock split would elevate us to Potentially the NASDAQ. The medical sector thankfully is doing well in the midst of a looming recession. If I was in charge this is what I would hope to achieve. Things have changed in the last year and the evaluation and the value of this company has increased by a multiple of 1000. There is big money involved now in my opinion which leads me to believe big Pharma , medicaid Medicare, possibly legislation has a role to play. All these things will slow the process immensely due to all the legal scrutiny that needs to happen to make sure it’s done right. So I do believe the longer this takes the better for us. Would I believe is about to happen to this small company is going to be very very big. If Darcy and the team can get Medicaid Medicare approval, provide a savings for the taxpayer, and involve the right governors senators lawmakers and don’t forget the big Pharma element as a potential partner or possibly buy out. This could be life-changing. Look at it this way Darcy Klug is already a very rich man and has a lot of very influential people in his Rolodex. The contacts and networking is paramount. To do anything but swing for the fences would be a waste of the man’s time. I think it’s safe to say we’re in for one hell of a ride. !!!!!!!
